Refining AML outcome prediction

Leukemia. 2019 Feb;33(2):283-284. doi: 10.1038/s41375-018-0317-4. Epub 2018 Dec 14.

Christopher S Hourigan¹, Robert Peter Gale², Roland B Walter^{3

4

5}

¹ Laboratory of Myeloid Malignancies, National Heart Lung and Blood Institute, 10 Center Drive, Bethesda, MD, USA. hourigan@nih.gov.
² Division of Experimental Medicine, Department of Medicine, Haematology Research Centre, Imperial College London, London, UK.
³ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁴ Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
⁵ Department of Epidemiology, University of Washington, Seattle, WA, USA.

No abstract available

Publication types